Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.
The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Gendered violence and women’s citizenship in Africa
2014-05-23

 
Prof Takyiwaa Manuh

Prof Takyiwaa Manuh celebrated both Africa Day and her birthday with the UFS on 22 May 2014.

Being the guest speaker at the Africa Day Memorial Lecture, Prof Manuh discussed how gendered violence and the lack of women’s true citizenship in Africa still hinder the Pan-African ideal. She asked the question: if African issues get less worldwide attention, how much less attention do African women get?

“Africa Day offers us an opportunity to revisit the Pan-African ideal and aspiration for total national liberation, equality and self-worth,” Prof Manuh said.

“This ideal has envisaged full citizenship with the enjoyment of rights and resources for the people of Africa to live a dignified and fulfilling life. Yet, the conceptions of citizenship that have emerged in several African countries do not fully incorporate women and girls.”

The lecture explored the policing of women’s bodies and sexualities and how their enjoyment of rights is undermined – often under the pretext of culture. Often families, communities, states, religious bodies and culture work collaboratively to mold African women into the patriarchal image of disciplined and virtuous. The epidemic of violence against females negates their fundamental human rights and their claim to full citizenship and protection within their states.

The lecture also reviewed recent efforts including law reform, legislation and actions by activists. “The African Union and the UN need to confront these violations and suggest a robust agenda for more effective exercise of women’s citizenship rights and convergence towards the Pan-African ideal.”

Prof Manuh is currently Director: Social Development Policy Division of the United Nations Economic Commission for Africa in Addis Ababa, Ethiopia.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept